Point72 Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Point72 Asset Management's NVO Position: Q3 2026 in Review
Point72 Asset Management increased its Novo Nordisk (NVO) stake by 995% in Q3 2026, buying an estimated $13.4M and bringing the position to 319,651 shares worth $12.1M. The position accounts for 0.01% of the portfolio, ranked #1238.
Point72 Asset Management first reported a position in NVO in Q4 2014 and has held it in 12 quarters since. The position peaked at $137M in Q2 2024. 1,223 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Point72 Asset Management held 319,651 shares of Novo Nordisk worth $12.1M as of Q3 2026.
- Point72 Asset Management bought 290,453 Novo Nordisk shares in Q3 2026, an estimated $13.4M.
- Novo Nordisk made up 0.01% of Point72 Asset Management's portfolio in Q3 2026, its #1238 holding.
- Point72 Asset Management first reported a position in Novo Nordisk in Q4 2014 and has held it in 12 quarters since.
- Point72 Asset Management's Novo Nordisk position peaked at $137M in Q2 2024.
- 1,223 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.